TCM
DXCM icon

Traynor Capital Management’s DexCom DXCM Stock Holding History

Traynor Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,901
Closed -$364K – 254
2023
Q3 		$364K Buy
3,901
+56
+1% +$6.31K 0.05% 144
2023
Q2 		$494K Buy
3,845
+1,670
+77% +$202K 0.06% 126
2023
Q1 		$253K Buy
+2,175
New +$243K 0.04% 160

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Traynor Capital Management's DXCM Position: Q4 2023 in Review

Traynor Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 3,901 shares — an estimated $364K sold.

Traynor Capital Management first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $494K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Traynor Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Traynor Capital Management sold 3,901 DexCom shares in Q4 2023, an estimated $364K.
  • Traynor Capital Management first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
  • Traynor Capital Management's DexCom position peaked at $494K in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Traynor Capital Management's 13F filing for Q4 2023, filed 18 Jan 2024.